Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
112,726,359
-
Share change
-
-4,616,554
-
Total reported value
-
$297,591,838
-
Put/Call ratio
-
93%
-
Price per share
-
$2.64
-
Number of holders
-
149
-
Value change
-
-$13,555,714
-
Number of buys
-
70
-
Number of sells
-
60
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q2 2021
As of 30 Jun 2021,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,726,359 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, MSD Partners, L.P., DISCOVERY CAPITAL MANAGEMENT, LLC / CT, STATE STREET CORP, MILLER VALUE PARTNERS, LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
149
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.